Administering AuNPs anchored with maize tetrapeptide can enhance the functioning of the central cholinergic system while decreasing acetylcholinesterase levels, which implies that the newly identified tetrapeptide prevents AD as a neuroprotective agent [34]. The gene discussed is ACHE; the disease is Alzheimer disease.